NMD Pharma A/S | LinkedIn
Well-financed biotech company to enter the clinic in 2020
NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round
Annual Report 2016 by Lundbeckfonden - issuu
BioLeader Interview - PIR International
AU 2016/279486 A1 - Compounds For Use In Treating Neuromuscular Disorders - The Lens - Free & Open Patent and Scholarly Search
Company Presentation
Claus Elsborg Olesen - Biography
Initiator Pharma | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma A/S | LinkedIn
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents
Claus OLESEN | Aarhus University | AU | Department of Biomedicine
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Company Presentation
Prominent Canadian researcher in Denmark: Why I left a top job in California
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile
Initiator Pharma
Initiator Pharma
NMD Pharma company information, funding & investors | Dealroom.co
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Initiator Pharma
